Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients

It has been revealed by our previous proteomic study that the expression profile is different between well-differentiated and poorly differentiated hepatocellular carcinoma (HCC). Among those differently expressed proteins, peroxiredoxin2 (PRDX2) was our protein of interest. The present study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Bing, Lin, Yanyan, Hu, Jinjing, Wang, Haiping, Li, Lu, Zhao, Sheng, Zhang, Jinduo, Meng, Wenbo, Yue, Ping, Bai, Zhongtian, Li, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365706/
https://www.ncbi.nlm.nih.gov/pubmed/30747220
http://dx.doi.org/10.3892/or.2019.6977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365706/
https://www.ncbi.nlm.nih.gov/pubmed/30747220
http://dx.doi.org/10.3892/or.2019.6977

Ejemplares similares